QuiaPEG

Newsroom

Mar 12, 2019

QuiaPEG Pharmaceuticals Holding AB (publ.) announces that a patent application within the fast-growing area of antibody drug conjugates* (ADC) has been submitted to the American patent office (USPTO). Granting of the application will mean that QuiaPEG will have patent protection up to and including 2013.

Download press release (PDF)
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message